specielt hos patienter med forhøjet risiko for bivirkninger, f. eks. patienter med astma eller kronisk obstruktiv lungesygdom.
The company that makes Exubera will carry out studies to further test its safety, particularly in patients who might have an increased risk of side effects, such as patients with asthma or chronic obstructive pulmonary disease.